Boeger, Carsten A. and Goetz, Angela and Stubanus, Mike and Banas, Bernhard and Deinzer, Martina and Krueger, Bernd and Holmer, Stephan R. and Schmitz, Gerd and Riegger, Guenter A. J. and Kramer, Bernhard K. (2005) C-reactive protein as predictor of death in end-stage diabetic nephropathy: Role of peripheral arterial disease. KIDNEY INTERNATIONAL, 68 (1). pp. 217-227. ISSN 0085-2538,
Full text not available from this repository. (Request a copy)Abstract
Background. Patients with diabetes type 2 receiving dialysis therapy have a poor survival prognosis, mainly due to cardiovascular events. Increased C-reactive protein (CRP) levels, important in atherosclerosis, are associated with an increased risk for cardiovascular events. However, to date no study has shown the predictive value of CRP in relation to peripheral arterial disease stage. Methods. We enrolled all 445 prevalent patients with diabetic nephropathy receiving maintenance hemodialysis in 30 centers in Southern Germany from August 1999 to January 2000 for prospective study until December 2003. At inclusion, CRP and a complete clinical phenotype, including peripheral arterial disease Fontaine Stage were determined. The primary end point was all-cause mortality. Results. A total of 305 (68.5%) patients died. An increased log CRP at study inclusion was significantly associated with an increase in hazard ratio (HR) by multivariate Cox regression for all-cause (HR = 1.5, P= 0.002) and cardiac death (HR = 1.76, P= 0.02) in the entire collective. This result was applicable only to patients with peripheral arterial disease Fontaine stage IV (N= 190, multivariate HR = 1.75 for all-cause mortality, P= 0.006). Possibly due to inadequate power, we observed only an insignificant trend for CRP as predictor of all-cause death in patients without peripheral arterial disease or with less severe forms of peripheral arterial disease (HR = 1.36, P= 0.08). Conclusion. In contrast to patients with peripheral arterial disease stage IV, patients with less severe atherosclerosis and elevated CRP are, if any, at less risk for cardiovascular mortality, possibly due to the difference in extent of affected vasculature and thus activated platelets and coagulation. Before judging the predictive value of CRP for mortality, peripheral vessel status should be determined.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | PERITONEAL-DIALYSIS PATIENTS; HUMAN ENDOTHELIAL-CELLS; CORONARY-HEART-DISEASE; CHRONIC-RENAL-FAILURE; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; MAINTENANCE HEMODIALYSIS; LONG-TERM; ATHEROSCLEROSIS; INFLAMMATION; dialysis; diabetic nephropathy; inflammation; survival; peripheral arterial disease; diabetes mellitus |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II Medicine > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 07 May 2021 12:04 |
| Last Modified: | 07 May 2021 12:04 |
| URI: | https://pred.uni-regensburg.de/id/eprint/35955 |
Actions (login required)
 |
View Item |
